KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Accumulated Expenses (2020 - 2025)

Organon has reported Accumulated Expenses over the past 6 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Accumulated Expenses at $1.3 billion for Q4 2025, down 5.39% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (down 5.39% YoY), and the annual figure for FY2025 was $1.3 billion, down 5.39%.
  • Accumulated Expenses for Q4 2025 was $1.3 billion at Organon, down from $1.4 billion in the prior quarter.
  • Over the last five years, Accumulated Expenses for OGN hit a ceiling of $1.5 billion in Q3 2024 and a floor of $759.0 million in Q1 2021.
  • Median Accumulated Expenses over the past 5 years was $1.2 billion (2022), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 54.93% in 2021 and later decreased 5.39% in 2025.
  • Organon's Accumulated Expenses stood at $1.0 billion in 2021, then rose by 16.36% to $1.2 billion in 2022, then grew by 16.92% to $1.4 billion in 2023, then grew by 1.58% to $1.4 billion in 2024, then dropped by 5.39% to $1.3 billion in 2025.
  • The last three reported values for Accumulated Expenses were $1.3 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.